Literature DB >> 11113859

Expression of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex correlates with the macroscopic appearance of early gastric cancer.

Y Ohene-Abuakwa1, M Noda, M Perenyi, N Kobayashi, K Kashima, T Hattori, M Pignatelli.   

Abstract

E-cadherin and its associated cytoplasmic proteins, alpha-, beta-, and gamma-catenins, play an essential role in the control of epithelial differentiation. We have previously shown that loss or down-regulation of E-cadherin/catenin correlates with poor survival in advanced gastric adenocarcinoma. The aim of this study was to assess the expression of E-cadherin and catenins in early gastric cancers (EGCs). Immunohistochemical staining for E-cadherin and alpha-, beta-, and gamma-catenins was performed on 41 paraffin-embedded gastrectomy specimens of EGC using an indirect immunoperoxidase technique. The pattern of expression and cellular localization of the E-cadherin/catenin complex in tumour cells were correlated with the macroscopic appearance of the tumour according to the Japanese Endoscopic Society classification. The tumours were classified as follows: three type I (protruding) and 38 type II (superficial), of which ten were type IIa (elevated), one was type IIb (flat), and 27 were type IIc (depressed). E-cadherin and alpha-, beta-, and gamma-catenins were expressed at the cell-cell junctions in normal mucosa. Forty out of 41 tumours showed abnormal expression (loss of membranous immunoreactivity and/or nuclear staining) of at least one component of the E-cadherin catenin complex. Loss of E-cadherin immunoreactivity was more frequently seen in type IIb (1/1, 100%) and type IIc (27/27, 100%) than in type I (1/3, 33%) and type IIa (1/10, 10%) (p<0.01). Abnormal expression of E-cadherin and alpha-catenin was more frequently seen in diffuse-type than in intestinal type tumours (p<0.05). Abnormal immunoreactivity of beta- and gamma-catenin, including nuclear localization, was observed in 34% and 7.3% of tumours, respectively, but there was no significant correlation with tumour type or endoscopic appearance. In conclusion, abnormal expression of the E-cadherin/catenin complex occurs in EGC and seems to correlate with macroscopic appearances. Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11113859     DOI: 10.1002/1096-9896(2000)9999:9999<::AID-PATH723>3.0.CO;2-V

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  11 in total

1.  Protein signatures for classification and prognosis of gastric cancer a signaling pathway-based approach.

Authors:  Daguang Wang; Fei Ye; Yabin Sun; Wei Li; Hongyi Liu; Jing Jiang; Yang Zhang; Chengkui Liu; Weihua Tong; Ling Gao; Yezhou Sun; Weijia Zhang; Terry Seetoe; Peng Lee; Jian Suo; David Y Zhang
Journal:  Am J Pathol       Date:  2011-08-18       Impact factor: 4.307

2.  Nuclear translocation of β-catenin correlates with CD44 upregulation in Helicobacter pylori-infected gastric carcinoma.

Authors:  Gopal Udhayakumar; Venkatraman Jayanthi; Niranjali Devaraj; Halagowder Devaraj
Journal:  Mol Cell Biochem       Date:  2011-06-16       Impact factor: 3.396

Review 3.  Curcumin and lung cancer--a review.

Authors:  Hiren J Mehta; Vipul Patel; Ruxana T Sadikot
Journal:  Target Oncol       Date:  2014-05-21       Impact factor: 4.493

Review 4.  Abnormal β-catenin immunohistochemical expression as a prognostic factor in gastric cancer: a meta-analysis.

Authors:  Li-Fu Li; Zheng-Jie Wei; Hong Sun; Bo Jiang
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

5.  The Potential Clinical Implications of Circulating Tumor Cells and Circulating Tumor Microemboli in Gastric Cancer.

Authors:  Emne A Abdallah; Alexcia C Braun; Bianca C T C P Flores; Laís Senda; Ana Cláudia Urvanegia; Vinicius Calsavara; Victor Hugo Fonseca de Jesus; Maria Fernanda Arruda Almeida; Maria Dirlei Begnami; Felipe J F Coimbra; Wilson Luiz da Costa; Diana Noronha Nunes; Emmanuel Dias-Neto; Ludmilla T Domingos Chinen
Journal:  Oncologist       Date:  2019-03-07

6.  Expression of E-cadherin and beta-catenin in gastric carcinoma and its correlation with the clinicopathological features and patient survival.

Authors:  Yong-Ning Zhou; Cai-Pu Xu; Biao Han; Min Li; Liang Qiao; Dian-Chun Fang; Jian-Min Yang
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

7.  Alpha-catenin expression is decreased in patients with gastric carcinoma.

Authors:  Yong-Ning Zhou; Cai-Pu Xu; Yu Chen; Biao Han; Shi-Ming Yang; Dian-Chun Fang
Journal:  World J Gastroenterol       Date:  2005-06-14       Impact factor: 5.742

8.  Mechanisms inactivating the gene for E-cadherin in sporadic gastric carcinomas.

Authors:  Yao-Chi Liu; Chen-Yang Shen; Hurng-Sheng Wu; Tsai-Yuan Hsieh; De-Chuan Chan; Cheng-Jueng Chen; Jyh-Cherng Yu; Cheng-Ping Yu; Horng-Jyh Harn; Peng-Jen Chen; Chung-Bao Hsieh; Teng-Wei Chen; Huan-Mieng Hsu
Journal:  World J Gastroenterol       Date:  2006-04-14       Impact factor: 5.742

9.  Expression of APC, β-catenin and E-cadherin in Tunisian patients with gastric adenocarcinoma: clinical significance.

Authors:  Dorra Ben Ayed-Guerfali; Basma Hassairi; Abdelmajid Khabir; Tahia Sellami-Boudawara; Ali Gargouri; Raja Mokdad-Gargouri
Journal:  Tumour Biol       Date:  2013-10-03

Review 10.  Bench to bedside and back again: molecular mechanisms of alpha-catenin function and roles in tumorigenesis.

Authors:  Jacqueline M Benjamin; W James Nelson
Journal:  Semin Cancer Biol       Date:  2007-09-04       Impact factor: 15.707

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.